Peter Goodhand

Chief Executive Officer, Global Alliance for Genomics and Health

Peter Goodhand is a leader in the global health sector as a senior executive and board member.
Peter played a key role in the creation of the Global Alliance for Genomics and Health
(GA4GH) and was appointed as its founding Executive Director in 2014, and as Chief Executive
Officer in 2018. From May 2016 to April 2018, he also served as the President of the Ontario
Institute for Cancer Research (OICR).

Prior to the GA4GH and OICR, he was the President and Chief Executive Officer of the Canadian
Cancer Society, Canada's largest health charity. Before joining the charitable sector, Goodhand
had a 20 year career in the global medical technology industry, including strategic leadership
roles with multinational healthcare companies such as American Cyanamid and Johnson &
Johnson; Board Chair and President of Canada’s Medical Device Industry association (MEDEC);
and as the founding Managing Director and then Board Chair of the Health Technology Exchange
(HTX).

Peter is currently a member of the Occupational Cancer Research Centre Steering
Committee, Co-chair of the Medical and Scientific Advisory Board of Global Genes, Co-chair of
the International 100K+ Cohorts Consortium (IHCC), a member of the of the Global Genomic
Medicine Collaboration (G2MC) Steering Committee, and a board member of Triphase.
He chaired the Government of Canada’s Expert working group on the future of medical isotope
production, and was a member of the Canadian delegation to the UN summit on noncommunicable
diseases.

Peter Goodhand
SNOMED International